Page 205 - MSU Digital Book
P. 205

10. Chisholm MA, Vollenweider LJ, Mulloy LL, Wynn JJ, Wade WE, DiPiro JT. Cost-benefit

                  analysis of a clinical pharmacist-managed medication assistance program in a renal
                  transplant clinic. Clin Transplant. 2000;14:304-7.
              11. Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA.

                  Improving outcomes of renal transplant recipients with behavioral adherence
                  contracts: a randomized controlled trial. Am J Transplant. 2013;13:2364-73.

              12. Joost R, Dörje F, Schwitulla J, Eckardt KU, Hugo C. Intensified pharmaceutical
                  care is improving immunosuppressive medication adherence in kidney transplant
                  recipients during the first post-transplant year: a quasi-experimental study. Nephrol

                  Dial Transplant. 2014;29:1597-607.
              13. Salcedo J, Agudelo N, Baena MI. Pharmacotherapy follow-up to transplanted

                  patients during hospitalization in Foundation Clinic Valle del Lili. Seguim
                  Farmacoter 2004;2:12–18.
              14. Maldonado AQ, Weeks DL, Bitterman AN, McCleary JA, Seiger TC, Carson RW, et

                  al. Changing transplant recipient education and inpatient transplant pharmacy
                  practices: a single-center perspective. Am J Health Syst Pharm. 2013;70:900-4.

              15. Tschida S, Aslam S, Khan TT, Sahli B, Shrank WH, Lal LS. Managing specialty
                  medication services through a specialty pharmacy program: the case of oral renal
                  transplant immunosuppressant medications. J Manag Care Pharm. 2013;19:26-41.

              16. Chisholm MA, Spivey CA, Mulloy LL. Effects of a medication assistance program
                  with medication therapy management on the health of renal transplant recipients.

                  Am J Health Syst Pharm. 2007;64:1506-12.
              17. Wang HY, Chan AL, Chen MT, Liao CH, Tian YF. Effects of pharmaceutical care
                  intervention by clinical pharmacists in renal transplant clinics. Transplant Proc.

                  2008;40:2319-23.
              18. Pinelli NR, Clark LM, Carrington AC, Carrington JL, Malinzak L, Patel A. Pharmacist

                  managed diabetes and cardiovascular risk reduction clinic in kidney transplant
                  recipients: bridging the gap in care transition. Diabetes Res Clin Pract. 2014;106:e64-7.
              19. Xu XF, Feng YT, Tian YF, Wang HY. Pharmaceutical care in kidney transplant

                  recipients: behavioral and physiologic outcomes at 12 months. Transplant Proc.
                  2018;50:2451-6.






              180
   200   201   202   203   204   205   206   207   208   209   210